Effect of Timed-Restricted Eating on Metabolic Health
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Sep 24, 2023
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific eating schedule called timed-restricted eating on health issues related to obesity and insulin resistance, which is when your body doesn't respond well to insulin, a hormone that helps manage blood sugar. The goal is to see how this eating pattern affects things like liver fat, inflammation, sleep quality, and brain function in people who have these conditions.
The trial is looking for people aged 18 to 65 who have a body mass index (BMI) over 30, which indicates obesity, and who also show signs of insulin resistance or prediabetes. To participate, individuals must have maintained a stable weight for three months before joining the study and must be healthy enough to give consent. Participants will follow a structured eating plan, and their progress will be monitored throughout the study. If you or someone you know is interested, it’s important to note that certain medical conditions, medication use, and lifestyle factors, like smoking or intense exercise, may exclude someone from participating.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Ability to provide informed consent;
- • BMI \> 30kg/m\^2;
- • Insulin resistance, as defined by fasting plasma insulin \> 62 pmol/L and/or prediabetes, as defined by fasting plasma glucose \> 5.3 and \< 7.0 mmol/L;
- • Stable weight for 3 months prior to study inclusion
- • For women, 1 year after last menstrual cycle
- Exclusion Criteria:
- • Use of any medication, except for those related to treatment of metabolic syndrome;
- • Any medical condition interfering with study outcomes or design;
- • History of any psychiatric disorder, including eating disorders;
- • Performing shift work
- • Performing intensive sports (\>3 hours/week);
- • Smoking;
- • Drugs abuse or alcohol abuse (\>3 units/day);
- • Contraindication for MRI;
- • Known lactose/gluten intolerance;
- • Known soy, egg, milk or peanut allergy;
- • Childhood onset of obesity
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Amsterdam, Noord Holland, Netherlands
Patients applied
Trial Officials
Mireille JM Serlie, MD PhD
Principal Investigator
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported